BioSpace News Archive

Business

Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei

Dr. Marshall will leave Sosei at the end of February 2018.

January 18, 2018
·
4 min read
Business

New Global Leaders Join CDISC Board of Directors

The Clinical Data Interchange Standards Consortium (CDISC) today announced Chris Decker and Pam Howard have joined its Board of Directors to serve three-year terms, which began 1 January 2018.

January 18, 2018
·
3 min read
Lone Star Bio

University of Kansas Release: Breakthrough Enables Screening Millions of Human Antibodies for New Drug Discovery

A paper just published in Nature Biotechnology outlines a pioneering method of screening a person’s diverse set of antibodies for rapid therapeutic discovery.

January 18, 2018
·
4 min read
FDA

Qiagen Wins Nod to Roll Out Its Diagnostic Test in Lung Cancer

The approval extends the labeling claim to include detection of EGFR mutations L681Q, G719X and S768I to aid the identification of NSCLC patients for whom GILOTRIF is indicated.

January 18, 2018
·
1 min read
Policy

Amerigen’s Petition Leads to U.S. Zytiga Patent Invalidation

Amerigen was represented during the hearings on IPR2016-00286 by William Hare of McNeely Hare & War LLP.

January 18, 2018
·
1 min read
Genetown

Audax Recapitalizes Belmont Instrument Corporation

Mirus Capital Advisors announced today that it acted as the exclusive financial advisor to Belmont Instrument Corporation, in its recapitalization with Audax.

January 18, 2018
·
2 min read
Genetown

Brooks Life Sciences to Present, Host and Exhibit at Phacilitate Cell and Gene Therapy Conference

Brooks Life Sciences announced the company’s participation in Phacilitate Cell and Gene Therapy 2018 conference.

January 18, 2018
·
2 min read
Drug Development

Celsion Corporation Provides Corporate Update and 2018 Outlook

A look at what’s in store for Celsion this year.

January 18, 2018
·
15 min read
Policy

MiMedx Comments on Magistrate Recommendation in the Company’s Lawsuit Against Short Sellers

The Company believes that the Magistrate’s recommendations are in error, and therefore MiMedx will be filing objections with the District Court Judge.

January 18, 2018
·
4 min read
Bio NC

Argos Announces One-for-Twenty Reverse Stock Split

The Board of Directors approved a one-for-twenty reverse split of the Company’s common stock that will take effect today, January 18, 2018 after the close of trading.

January 18, 2018
·
5 min read